Neisseria Meningitidis, Serogroup C, Polysaccharide, Conjugated To Tetanus Toxoid, Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein, Neisseria Meningitidis Group W-135 Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein, Neisseria Meningitidis Group Y Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein

3 trials JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

7 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Indications tested

Chronic spontaneous urticaria 1 Meningococcal infection 1

Sponsors using this IMP

Sanofi Pasteur 2 Fraunhofer Institute For Translational Medicine And Pharmacology ITMP 1

All trials

3 total

Safety and immunogenicity of an investigational Pentavalent Meningococcal ABCYW vaccine against meningococcal disease in children, toddlers,… Ended

2023-510465-10-00 Phase II 6 countries Sanofi Pasteur Inc.
Study on immunogenicity and safety of a meningococcal ACYW conjugate vaccine in healthy infants and toddlers Ended

2023-508177-85-00 Phase III 6 countries Sanofi Pasteur
Proof of concept study to assess the efficacy and safety of Danicopan (factor D inhibitor) in adult patients with chronic spontaneous urtica… Ended

2024-512386-14-00 Phase II 1 country Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Showing 1–3 of 3 trials

← All drugs A–Z